Gastroenterology Research and Practice / 2016 / Article / Tab 3

Research Article

Prevalence and Risk Factors of Gastric Adenoma and Gastric Cancer in Colorectal Cancer Patients

Table 3

Comparison of baseline characteristics and endoscopic findings in the subjects with colorectal cancer patients and control group.

VariablesColorectal cancer patients ()Control group
()
value

Sex0.105
 Male91 (64.1%)240 (56.3%)
 Female51 (35.9%)186 (43.7%)
Age (yrs)65.63 ± 10.9861.87 ± 9.990.184
Body weight (kg)59.06 ± 9.2364.67 ± 11.020.023
BMI (body mass index, kg/m2)22.71 ± 3.0323.97 ± 3.290.583
Hypertension45 (31.7%)110 (25.8%)0.174
Diabetes29 (20.4%)55 (12.9%)0.029
Smoking33 (23.2%)71 (16.7%)0.079
Alcohol45 (31.7%)162 (38.0%)0.174
Family history (solid tumor)16 (11.3%)103 (24.2%)0.001
Follow-up period (months)28.3 ± 25.1144.4 ± 25.370.577
Baseline endoscopic findings
 Chronic atrophic gastritis80 (56.3%)267 (62.7%)0.180
 Intestinal metaplasia15 (10.6%)24 (5.6%)0.044
 Gastric ulcer2 (1.4%)4 (0.9%)0.636
 Duodenal ulcer3 (2.1%)8 (1.9%)0.860
 Hyperplastic polyp2 (1.4%)20 (4.7%)0.079
 Gastric adenoma3 (2.1%)7 (1.6%)0.713
 Gastric cancer10 (7.0%)2 (0.5%)<0.001
 Subepithelial tumor (SET)3 (2.1%)0 (0%)0.003

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.